TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹4,373 Cr | ₹3,704 Cr | ₹3,364 Cr | ₹2,824 Cr | ₹2,431 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹4,373 Cr |
| Mar2025 | ₹3,704 Cr |
| Mar2024 | ₹3,364 Cr |
| Mar2023 | ₹2,824 Cr |
| Mar2022 | ₹2,431 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,373 Cr | 18.05 | |
| Mar2025 | ₹3,704 Cr | 10.13 | |
| Mar2024 | ₹3,364 Cr | 19.11 | |
| Mar2023 | ₹2,824 Cr | 16.15 | |
| Mar2022 | ₹2,431 Cr | - | |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹178,405.7 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
| MANKIND PHARMA | ₹108,424.0 Cr | 3% | 13.9% | 17.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -2.3% |
1.5% |
23.6% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses